Boston at the 58th AASLD Annual Meeting in Boston. undetectable virus in the blood at 24 weeks post-48 weeks of treatment. quality of life and daily activity. mcg every two weeks group ; and 18.2 % for the 1800 mcg every two weeks group. reductions , and returned to baseline following the completion of therapy .